Cost-Utility of Geriatric Assessment and Management in Older Adults With Cancer: Model-Based Economic Evaluation
GAM is overall cost effective, with results varying across trial scenarios due to differences in chemotherapy dose intensity, hospitalization rates, and associated costs. Future research should prioritize identifying optimal core GAM components, delivery mode, and patient selection criteria to enhance its effectiveness and cost-effectiveness.
Authors
- Shabbir M.H. Alibhai (ORCID: https://orcid.org/0000-0001-7815-6046)
- Wee Kheng Soo (ORCID: https://orcid.org/0000-0002-5774-9800)
- Mostafa Mohamed (ORCID: https://orcid.org/0000-0003-2936-5794)
- Selai Akseer (ORCID: https://orcid.org/0000-0001-5851-0909)
- Yeva Sahakyan (ORCID: https://orcid.org/0000-0002-7216-064X)
- Shant Torkom Yeretzian (ORCID: https://orcid.org/0000-0001-7620-8551)
- Martine Puts (ORCID: https://orcid.org/0000-0002-0710-1854)
- Lusine Abrahamyan (ORCID: https://orcid.org/0000-0003-2788-4179)
Institutions
- University Health Network (CA)
- University of Toronto (CA)
- Toronto General Hospital (CA)
- Eastern Health (AU)
- University of Rochester (US)
- Monash University (AU)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2025-10-21
- DOI
- https://doi.org/10.1200/jco-25-00248
- Citations
- 1
- Primary Topic
- Frailty in Older Adults
- Type
- article
- Field-Weighted Citation Impact
- 1.22